
Deals7 April 2026 at 05:11 pm
Novartis AG Makes No Encumbrance of Equity Shares in Novartis India Ltd as of March 31, 2026
AI Summary
Novartis AG, the promoter of Novartis India Limited, has declared that it has not made any encumbrance of the company's equity shares as of March 31, 2026, in accordance with the SEBI Regulations. Additionally, Novartis AG has entered into an agreement for the sale and purchase of 1,74,50,680 equity shares, which represents 70.68% of the equity share capital, with WaveRise Investments Limited, ChrysCapital Fund X, and Two Infinity Partners. This agreement was made on February 19, 2026.
Key Highlights
- Novartis AG has not made any encumbrance of Novartis India Limited's equity shares as of March 31, 2026.
- Novartis AG has agreed to sell 1,74,50,680 equity shares to WaveRise Investments Limited, ChrysCapital Fund X, and Two Infinity Partners.
- The sale represents 70.68% of the equity share capital of Novartis India Limited.
- The agreement for the sale and purchase was made on February 19, 2026.
- Novartis AG is the promoter of Novartis India Limited.
NOVARTINDPharmaceuticals
NOVARTIS INDIA LTD.Price Impact